Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Ketorolac Tromethamine Market Growth 2022-2028

  • LP 4798454
  • 114 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Ketorolac Tromethamine will have significant change from previous year. According to our (LP Information) latest study, the global Ketorolac Tromethamine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Ketorolac Tromethamine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Ketorolac Tromethamine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ketorolac Tromethamine market, reaching US$ million by the year 2028. As for the Europe Ketorolac Tromethamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Ketorolac Tromethamine players cover Pfizer, Omeros Corporation, Egalet US Inc., and Allergan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Ketorolac Tromethamine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Injection

Ophthalmic

Nasal

Oral tablet

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Short-term treatment of pain

Ophthalmic Surgery

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Omeros Corporation

Egalet US Inc.

Allergan

Dr. Reddy’s Laboratories

Teva

Mylan

West Ward Pharmaceuticals

Fresenius Kabi

Apotex

Sandoz

Amphastar Pharmaceuticals

Gland Pharma Limited

Akorn

Sun Pharmaceutical

Sagent Pharmaceuticals

Aurobindo Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ketorolac Tromethamine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ketorolac Tromethamine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ketorolac Tromethamine by Country/Region, 2017, 2022 & 2028

2.2 Ketorolac Tromethamine Segment by Type

2.2.1 Injection

2.2.2 Ophthalmic

2.2.3 Nasal

2.2.4 Oral tablet

2.3 Ketorolac Tromethamine Sales by Type

2.3.1 Global Ketorolac Tromethamine Sales Market Share by Type (2017-2022)

2.3.2 Global Ketorolac Tromethamine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ketorolac Tromethamine Sale Price by Type (2017-2022)

2.4 Ketorolac Tromethamine Segment by Application

2.4.1 Short-term treatment of pain

2.4.2 Ophthalmic Surgery

2.5 Ketorolac Tromethamine Sales by Application

2.5.1 Global Ketorolac Tromethamine Sale Market Share by Application (2017-2022)

2.5.2 Global Ketorolac Tromethamine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ketorolac Tromethamine Sale Price by Application (2017-2022)

3 Global Ketorolac Tromethamine by Company

3.1 Global Ketorolac Tromethamine Breakdown Data by Company

3.1.1 Global Ketorolac Tromethamine Annual Sales by Company (2020-2022)

3.1.2 Global Ketorolac Tromethamine Sales Market Share by Company (2020-2022)

3.2 Global Ketorolac Tromethamine Annual Revenue by Company (2020-2022)

3.2.1 Global Ketorolac Tromethamine Revenue by Company (2020-2022)

3.2.2 Global Ketorolac Tromethamine Revenue Market Share by Company (2020-2022)

3.3 Global Ketorolac Tromethamine Sale Price by Company

3.4 Key Manufacturers Ketorolac Tromethamine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ketorolac Tromethamine Product Location Distribution

3.4.2 Players Ketorolac Tromethamine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ketorolac Tromethamine by Geographic Region

4.1 World Historic Ketorolac Tromethamine Market Size by Geographic Region (2017-2022)

4.1.1 Global Ketorolac Tromethamine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ketorolac Tromethamine Annual Revenue by Geographic Region

4.2 World Historic Ketorolac Tromethamine Market Size by Country/Region (2017-2022)

4.2.1 Global Ketorolac Tromethamine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ketorolac Tromethamine Annual Revenue by Country/Region

4.3 Americas Ketorolac Tromethamine Sales Growth

4.4 APAC Ketorolac Tromethamine Sales Growth

4.5 Europe Ketorolac Tromethamine Sales Growth

4.6 Middle East & Africa Ketorolac Tromethamine Sales Growth

5 Americas

5.1 Americas Ketorolac Tromethamine Sales by Country

5.1.1 Americas Ketorolac Tromethamine Sales by Country (2017-2022)

5.1.2 Americas Ketorolac Tromethamine Revenue by Country (2017-2022)

5.2 Americas Ketorolac Tromethamine Sales by Type

5.3 Americas Ketorolac Tromethamine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ketorolac Tromethamine Sales by Region

6.1.1 APAC Ketorolac Tromethamine Sales by Region (2017-2022)

6.1.2 APAC Ketorolac Tromethamine Revenue by Region (2017-2022)

6.2 APAC Ketorolac Tromethamine Sales by Type

6.3 APAC Ketorolac Tromethamine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ketorolac Tromethamine by Country

7.1.1 Europe Ketorolac Tromethamine Sales by Country (2017-2022)

7.1.2 Europe Ketorolac Tromethamine Revenue by Country (2017-2022)

7.2 Europe Ketorolac Tromethamine Sales by Type

7.3 Europe Ketorolac Tromethamine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ketorolac Tromethamine by Country

8.1.1 Middle East & Africa Ketorolac Tromethamine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ketorolac Tromethamine Revenue by Country (2017-2022)

8.2 Middle East & Africa Ketorolac Tromethamine Sales by Type

8.3 Middle East & Africa Ketorolac Tromethamine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ketorolac Tromethamine

10.3 Manufacturing Process Analysis of Ketorolac Tromethamine

10.4 Industry Chain Structure of Ketorolac Tromethamine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ketorolac Tromethamine Distributors

11.3 Ketorolac Tromethamine Customer

12 World Forecast Review for Ketorolac Tromethamine by Geographic Region

12.1 Global Ketorolac Tromethamine Market Size Forecast by Region

12.1.1 Global Ketorolac Tromethamine Forecast by Region (2023-2028)

12.1.2 Global Ketorolac Tromethamine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ketorolac Tromethamine Forecast by Type

12.7 Global Ketorolac Tromethamine Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Ketorolac Tromethamine Product Offered

13.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Omeros Corporation

13.2.1 Omeros Corporation Company Information

13.2.2 Omeros Corporation Ketorolac Tromethamine Product Offered

13.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Omeros Corporation Main Business Overview

13.2.5 Omeros Corporation Latest Developments

13.3 Egalet US Inc.

13.3.1 Egalet US Inc. Company Information

13.3.2 Egalet US Inc. Ketorolac Tromethamine Product Offered

13.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Egalet US Inc. Main Business Overview

13.3.5 Egalet US Inc. Latest Developments

13.4 Allergan

13.4.1 Allergan Company Information

13.4.2 Allergan Ketorolac Tromethamine Product Offered

13.4.3 Allergan Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Allergan Main Business Overview

13.4.5 Allergan Latest Developments

13.5 Dr. Reddy’s Laboratories

13.5.1 Dr. Reddy’s Laboratories Company Information

13.5.2 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Offered

13.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Dr. Reddy’s Laboratories Main Business Overview

13.5.5 Dr. Reddy’s Laboratories Latest Developments

13.6 Teva

13.6.1 Teva Company Information

13.6.2 Teva Ketorolac Tromethamine Product Offered

13.6.3 Teva Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Teva Main Business Overview

13.6.5 Teva Latest Developments

13.7 Mylan

13.7.1 Mylan Company Information

13.7.2 Mylan Ketorolac Tromethamine Product Offered

13.7.3 Mylan Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mylan Main Business Overview

13.7.5 Mylan Latest Developments

13.8 West Ward Pharmaceuticals

13.8.1 West Ward Pharmaceuticals Company Information

13.8.2 West Ward Pharmaceuticals Ketorolac Tromethamine Product Offered

13.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 West Ward Pharmaceuticals Main Business Overview

13.8.5 West Ward Pharmaceuticals Latest Developments

13.9 Fresenius Kabi

13.9.1 Fresenius Kabi Company Information

13.9.2 Fresenius Kabi Ketorolac Tromethamine Product Offered

13.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Fresenius Kabi Main Business Overview

13.9.5 Fresenius Kabi Latest Developments

13.10 Apotex

13.10.1 Apotex Company Information

13.10.2 Apotex Ketorolac Tromethamine Product Offered

13.10.3 Apotex Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Apotex Main Business Overview

13.10.5 Apotex Latest Developments

13.11 Sandoz

13.11.1 Sandoz Company Information

13.11.2 Sandoz Ketorolac Tromethamine Product Offered

13.11.3 Sandoz Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sandoz Main Business Overview

13.11.5 Sandoz Latest Developments

13.12 Amphastar Pharmaceuticals

13.12.1 Amphastar Pharmaceuticals Company Information

13.12.2 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Offered

13.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Amphastar Pharmaceuticals Main Business Overview

13.12.5 Amphastar Pharmaceuticals Latest Developments

13.13 Gland Pharma Limited

13.13.1 Gland Pharma Limited Company Information

13.13.2 Gland Pharma Limited Ketorolac Tromethamine Product Offered

13.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Gland Pharma Limited Main Business Overview

13.13.5 Gland Pharma Limited Latest Developments

13.14 Akorn

13.14.1 Akorn Company Information

13.14.2 Akorn Ketorolac Tromethamine Product Offered

13.14.3 Akorn Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Akorn Main Business Overview

13.14.5 Akorn Latest Developments

13.15 Sun Pharmaceutical

13.15.1 Sun Pharmaceutical Company Information

13.15.2 Sun Pharmaceutical Ketorolac Tromethamine Product Offered

13.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Sun Pharmaceutical Main Business Overview

13.15.5 Sun Pharmaceutical Latest Developments

13.16 Sagent Pharmaceuticals

13.16.1 Sagent Pharmaceuticals Company Information

13.16.2 Sagent Pharmaceuticals Ketorolac Tromethamine Product Offered

13.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sagent Pharmaceuticals Main Business Overview

13.16.5 Sagent Pharmaceuticals Latest Developments

13.17 Aurobindo Pharma

13.17.1 Aurobindo Pharma Company Information

13.17.2 Aurobindo Pharma Ketorolac Tromethamine Product Offered

13.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Aurobindo Pharma Main Business Overview

13.17.5 Aurobindo Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Ketorolac Tromethamine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ketorolac Tromethamine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Injection

Table 4. Major Players of Ophthalmic

Table 5. Major Players of Nasal

Table 6. Major Players of Oral tablet

Table 7. Global Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 8. Global Ketorolac Tromethamine Sales Market Share by Type (2017-2022)

Table 9. Global Ketorolac Tromethamine Revenue by Type (2017-2022) & ($ million)

Table 10. Global Ketorolac Tromethamine Revenue Market Share by Type (2017-2022)

Table 11. Global Ketorolac Tromethamine Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 13. Global Ketorolac Tromethamine Sales Market Share by Application (2017-2022)

Table 14. Global Ketorolac Tromethamine Revenue by Application (2017-2022)

Table 15. Global Ketorolac Tromethamine Revenue Market Share by Application (2017-2022)

Table 16. Global Ketorolac Tromethamine Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Ketorolac Tromethamine Sales by Company (2020-2022) & (K Units)

Table 18. Global Ketorolac Tromethamine Sales Market Share by Company (2020-2022)

Table 19. Global Ketorolac Tromethamine Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Ketorolac Tromethamine Revenue Market Share by Company (2020-2022)

Table 21. Global Ketorolac Tromethamine Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Ketorolac Tromethamine Producing Area Distribution and Sales Area

Table 23. Players Ketorolac Tromethamine Products Offered

Table 24. Ketorolac Tromethamine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Ketorolac Tromethamine Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Ketorolac Tromethamine Sales Market Share Geographic Region (2017-2022)

Table 29. Global Ketorolac Tromethamine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Ketorolac Tromethamine Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Ketorolac Tromethamine Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Ketorolac Tromethamine Sales Market Share by Country/Region (2017-2022)

Table 33. Global Ketorolac Tromethamine Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Ketorolac Tromethamine Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)

Table 36. Americas Ketorolac Tromethamine Sales Market Share by Country (2017-2022)

Table 37. Americas Ketorolac Tromethamine Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Ketorolac Tromethamine Revenue Market Share by Country (2017-2022)

Table 39. Americas Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 40. Americas Ketorolac Tromethamine Sales Market Share by Type (2017-2022)

Table 41. Americas Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 42. Americas Ketorolac Tromethamine Sales Market Share by Application (2017-2022)

Table 43. APAC Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units)

Table 44. APAC Ketorolac Tromethamine Sales Market Share by Region (2017-2022)

Table 45. APAC Ketorolac Tromethamine Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Ketorolac Tromethamine Revenue Market Share by Region (2017-2022)

Table 47. APAC Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 48. APAC Ketorolac Tromethamine Sales Market Share by Type (2017-2022)

Table 49. APAC Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 50. APAC Ketorolac Tromethamine Sales Market Share by Application (2017-2022)

Table 51. Europe Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)

Table 52. Europe Ketorolac Tromethamine Sales Market Share by Country (2017-2022)

Table 53. Europe Ketorolac Tromethamine Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Ketorolac Tromethamine Revenue Market Share by Country (2017-2022)

Table 55. Europe Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 56. Europe Ketorolac Tromethamine Sales Market Share by Type (2017-2022)

Table 57. Europe Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 58. Europe Ketorolac Tromethamine Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Ketorolac Tromethamine Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Ketorolac Tromethamine

Table 68. Key Market Challenges & Risks of Ketorolac Tromethamine

Table 69. Key Industry Trends of Ketorolac Tromethamine

Table 70. Ketorolac Tromethamine Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Ketorolac Tromethamine Distributors List

Table 73. Ketorolac Tromethamine Customer List

Table 74. Global Ketorolac Tromethamine Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Ketorolac Tromethamine Sales Market Forecast by Region

Table 76. Global Ketorolac Tromethamine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Ketorolac Tromethamine Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Ketorolac Tromethamine Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Ketorolac Tromethamine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Ketorolac Tromethamine Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Ketorolac Tromethamine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Ketorolac Tromethamine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Ketorolac Tromethamine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Ketorolac Tromethamine Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Ketorolac Tromethamine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Ketorolac Tromethamine Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Ketorolac Tromethamine Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Ketorolac Tromethamine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Ketorolac Tromethamine Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Ketorolac Tromethamine Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Ketorolac Tromethamine Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Ketorolac Tromethamine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Ketorolac Tromethamine Revenue Market Share Forecast by Application (2023-2028)

Table 94. Pfizer Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 95. Pfizer Ketorolac Tromethamine Product Offered

Table 96. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Pfizer Main Business

Table 98. Pfizer Latest Developments

Table 99. Omeros Corporation Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 100. Omeros Corporation Ketorolac Tromethamine Product Offered

Table 101. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Omeros Corporation Main Business

Table 103. Omeros Corporation Latest Developments

Table 104. Egalet US Inc. Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 105. Egalet US Inc. Ketorolac Tromethamine Product Offered

Table 106. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Egalet US Inc. Main Business

Table 108. Egalet US Inc. Latest Developments

Table 109. Allergan Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 110. Allergan Ketorolac Tromethamine Product Offered

Table 111. Allergan Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Allergan Main Business

Table 113. Allergan Latest Developments

Table 114. Dr. Reddy’s Laboratories Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 115. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Offered

Table 116. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Dr. Reddy’s Laboratories Main Business

Table 118. Dr. Reddy’s Laboratories Latest Developments

Table 119. Teva Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 120. Teva Ketorolac Tromethamine Product Offered

Table 121. Teva Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Teva Main Business

Table 123. Teva Latest Developments

Table 124. Mylan Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 125. Mylan Ketorolac Tromethamine Product Offered

Table 126. Mylan Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Mylan Main Business

Table 128. Mylan Latest Developments

Table 129. West Ward Pharmaceuticals Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 130. West Ward Pharmaceuticals Ketorolac Tromethamine Product Offered

Table 131. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. West Ward Pharmaceuticals Main Business

Table 133. West Ward Pharmaceuticals Latest Developments

Table 134. Fresenius Kabi Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 135. Fresenius Kabi Ketorolac Tromethamine Product Offered

Table 136. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Fresenius Kabi Main Business

Table 138. Fresenius Kabi Latest Developments

Table 139. Apotex Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 140. Apotex Ketorolac Tromethamine Product Offered

Table 141. Apotex Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Apotex Main Business

Table 143. Apotex Latest Developments

Table 144. Sandoz Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 145. Sandoz Ketorolac Tromethamine Product Offered

Table 146. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Sandoz Main Business

Table 148. Sandoz Latest Developments

Table 149. Amphastar Pharmaceuticals Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 150. Amphastar Pharmaceuticals Ketorolac Tromethamine Product Offered

Table 151. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Amphastar Pharmaceuticals Main Business

Table 153. Amphastar Pharmaceuticals Latest Developments

Table 154. Gland Pharma Limited Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 155. Gland Pharma Limited Ketorolac Tromethamine Product Offered

Table 156. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Gland Pharma Limited Main Business

Table 158. Gland Pharma Limited Latest Developments

Table 159. Akorn Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 160. Akorn Ketorolac Tromethamine Product Offered

Table 161. Akorn Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 162. Akorn Main Business

Table 163. Akorn Latest Developments

Table 164. Sun Pharmaceutical Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 165. Sun Pharmaceutical Ketorolac Tromethamine Product Offered

Table 166. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 167. Sun Pharmaceutical Main Business

Table 168. Sun Pharmaceutical Latest Developments

Table 169. Sagent Pharmaceuticals Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 170. Sagent Pharmaceuticals Ketorolac Tromethamine Product Offered

Table 171. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 172. Sagent Pharmaceuticals Main Business

Table 173. Sagent Pharmaceuticals Latest Developments

Table 174. Aurobindo Pharma Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors

Table 175. Aurobindo Pharma Ketorolac Tromethamine Product Offered

Table 176. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 177. Aurobindo Pharma Main Business

Table 178. Aurobindo Pharma Latest Developments

List of Figures

Figure 1. Picture of Ketorolac Tromethamine

Figure 2. Ketorolac Tromethamine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ketorolac Tromethamine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Ketorolac Tromethamine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ketorolac Tromethamine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Injection

Figure 10. Product Picture of Ophthalmic

Figure 11. Product Picture of Nasal

Figure 12. Product Picture of Oral tablet

Figure 13. Global Ketorolac Tromethamine Sales Market Share by Type in 2021

Figure 14. Global Ketorolac Tromethamine Revenue Market Share by Type (2017-2022)

Figure 15. Ketorolac Tromethamine Consumed in Short-term treatment of pain

Figure 16. Global Ketorolac Tromethamine Market: Short-term treatment of pain (2017-2022) & (K Units)

Figure 17. Ketorolac Tromethamine Consumed in Ophthalmic Surgery

Figure 18. Global Ketorolac Tromethamine Market: Ophthalmic Surgery (2017-2022) & (K Units)

Figure 19. Global Ketorolac Tromethamine Sales Market Share by Application (2017-2022)

Figure 20. Global Ketorolac Tromethamine Revenue Market Share by Application in 2021

Figure 21. Ketorolac Tromethamine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Ketorolac Tromethamine Revenue Market Share by Company in 2021

Figure 23. Global Ketorolac Tromethamine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Ketorolac Tromethamine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Ketorolac Tromethamine Sales Market Share by Region (2017-2022)

Figure 26. Global Ketorolac Tromethamine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Ketorolac Tromethamine Sales 2017-2022 (K Units)

Figure 28. Americas Ketorolac Tromethamine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Ketorolac Tromethamine Sales 2017-2022 (K Units)

Figure 30. APAC Ketorolac Tromethamine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Ketorolac Tromethamine Sales 2017-2022 (K Units)

Figure 32. Europe Ketorolac Tromethamine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Ketorolac Tromethamine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Ketorolac Tromethamine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Ketorolac Tromethamine Sales Market Share by Country in 2021

Figure 36. Americas Ketorolac Tromethamine Revenue Market Share by Country in 2021

Figure 37. United States Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Ketorolac Tromethamine Sales Market Share by Region in 2021

Figure 42. APAC Ketorolac Tromethamine Revenue Market Share by Regions in 2021

Figure 43. China Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Ketorolac Tromethamine Sales Market Share by Country in 2021

Figure 50. Europe Ketorolac Tromethamine Revenue Market Share by Country in 2021

Figure 51. Germany Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Country in 2021

Figure 58. Egypt Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Ketorolac Tromethamine in 2021

Figure 64. Manufacturing Process Analysis of Ketorolac Tromethamine

Figure 65. Industry Chain Structure of Ketorolac Tromethamine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390